Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib vs High-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT00048230Phase 3Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jun 2002
- Primary completion
- Jul 2004
- Modality
- Small Molecules, Modified Peptides
- Countries
- 13
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Started Jun 2002; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00048230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048230.